Clinical Trial Update: A Clinical Research About CD70-targeted CAR-NKT Cells Therapy in Subjects with Advanced Malignant Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating CD70-targeted CAR-NKT cell therapy for advanced malignant solid tumors; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• CD70-targeted CAR-NKT Cells

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Advanced Malignant Solid Tumors | Phase 1 | Status: RECRUITING